AK
Anand Kumar Chettipalli
About Anand Kumar Chettipalli
Data last updated:
Anand Kumar Chettipalli is a Director at Abv Multispeciality Hospital Private Limited (since 2021) and Director at Wens Diagnostics Private Limited (since 2023). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹9.39 Cr; the largest is Abv Multispeciality Hospital Private Limited at ₹6.84 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Abv Multispeciality Hospital Private Limited U85100TG2021PTC157908 | Director | 14 Dec 2021 | 2021 | ₹6.84 Cr (FY 2024) | Active |
| Wens Diagnostics Private Limited U86905TS2023PTC175302 | Director | 24 Jul 2023 | 2023 | ₹2.55 Cr (FY 2025) | Active |
Board colleagues of Anand Kumar Chettipalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sivarchaka Bhargavi | 09435803 | Abv Multispeciality Hospital Private Limited , Wens Diagnostics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anand Kumar Chettipalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anand Kumar Chettipalli
Anand Kumar Chettipalli currently holds 2 directorships: Abv Multispeciality Hospital Private Limited (Director, since 14 Dec 2021, revenue ₹6.84 Cr (FY 2024)); Wens Diagnostics Private Limited (Director, since 24 Jul 2023, revenue ₹2.55 Cr (FY 2025)).
Anand Kumar Chettipalli was first appointed on 14 Dec 2021 as Director at Abv Multispeciality Hospital Private Limited. The most recent appointment on record is 24 Jul 2023 at Wens Diagnostics Private Limited.
The 2 current companies of Anand Kumar Chettipalli that report revenue have a combined latest revenue of ₹9.39 Cr: Abv Multispeciality Hospital Private Limited ₹6.84 Cr (FY 2024); Wens Diagnostics Private Limited ₹2.55 Cr (FY 2025).
The current boards of Anand Kumar Chettipalli's companies include Sivarchaka Bhargavi (Abv Multispeciality Hospital Private Limited).